Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study (Q57300568)

2

0 references

G. Kronborg

3

0 references

C. S. Larsen

4

0 references

P. R. Hildebrandt

5

0 references

H. T. Sorensen

6

0 references

J. Gerstoft

Clinical Infectious Diseases

7

0 references

language of work or name

English

0 references

publication date

15 June 2007

0 references

published in

0 references

volume

44

0 references

issue

12

0 references

page(s)

1625-1631

0 references

cites work

Cardiovascular disease in HIV-positive patients.

1 reference

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure

21 January 2018

1 reference

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

21 January 2018

1 reference

Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use

21 January 2018

1 reference

Epidemiology. When an entire country is a cohort

21 January 2018

1 reference

Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study

21 January 2018

1 reference

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

21 January 2018

1 reference

Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed.

21 January 2018

1 reference

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children

21 January 2018

1 reference

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

Health consequences of smoking 1-4 cigarettes per day.

21 January 2018

1 reference

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

1 reference